Overview We are a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN ) therapeutics. CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities not present in those same elements in bulk form. These catalytic activities drive, support, and maintain beneficial metabolic and energetic cellular reactions within ...
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2025-12-31 | 0001437749-26-008502 | EDGAR | 109K words |
| 2025-03-24 | 2024-12-31 | 0001437749-25-008956 | EDGAR | — |
| 2024-03-13 | 2023-12-31 | 0001437749-24-007542 | EDGAR | — |
| 2023-03-13 | 2022-12-31 | 0001437749-23-006264 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0000950170-22-003410 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001213900-21-018061 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001437749-25-034613 | EDGAR | 39K words |
| 2025-08-14 | 2025-06-30 | 0001437749-25-026679 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001437749-25-014918 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001437749-24-034663 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001437749-24-025014 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001437749-24-015209 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001437749-23-030487 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001437749-23-023409 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001437749-23-014242 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022333 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017214 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0000950170-22-008241 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-17 | 0001437749-26-008482 | EDGAR | 4K words |
| 2026-03-12 | 0001437749-26-007828 | EDGAR | — |
| 2026-02-24 | 0001437749-26-005156 | EDGAR | — |
| 2026-01-13 | 0001437749-26-001196 | EDGAR | — |
| 2026-01-12 | 0001437749-26-001049 | EDGAR | — |
| 2025-12-03 | 0001437749-25-036713 | EDGAR | — |
| 2025-12-03 | 0001437749-25-036712 | EDGAR | — |
| 2025-11-13 | 0001437749-25-034621 | EDGAR | — |
| 2025-10-17 | 0001437749-25-031277 | EDGAR | — |
| 2025-10-14 | 0001437749-25-030891 | EDGAR | — |
176 total filings indexed. 148 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001822791 |
| Ticker | CLNN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.clene.com |
| Listed | 2020-12-31 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report